Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-013877
Filing Date
2022-04-07
Accepted
2022-04-07 17:00:56
Documents
7
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A pstv-def14a_20220516.htm DEF 14A 1216099
2 GRAPHIC gdtdc5zscevp000005.jpg GRAPHIC 11795
3 GRAPHIC gdtdc5zscevp000002.jpg GRAPHIC 11795
4 GRAPHIC gdtdc5zscevp000006.jpg GRAPHIC 768834
5 GRAPHIC gdtdc5zscevp000001.jpg GRAPHIC 49190
6 GRAPHIC gdtdc5zscevp000004.jpg GRAPHIC 11795
7 GRAPHIC gdtdc5zscevp000007.jpg GRAPHIC 470905
  Complete submission text file 0001564590-22-013877.txt   3037662
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 22814546
SIC: 3841 Surgical & Medical Instruments & Apparatus